Xiaoting Peng | Bio-Medical Materials and Engineering | Best Researcher Award

Dr. Xiaoting Peng | Bio-Medical Materials and Engineering | Best Researcher Award

Postdoctor, University of Health and Rehabilitation Sciences, China

Dr. Peng Xiaoting is a dedicated postdoctoral researcher at the University of Health and Rehabilitation Sciences, specializing in the development of advanced biomaterials. Her research focuses on creating innovative biomaterials with unique chemical, physical, and biological properties, aimed at improving the diagnosis and treatment of complex diseases such as cancer, tissue injury, and defects. Dr. Peng’s groundbreaking work in the field of biomedical engineering is paving the way for personalized and effective therapies. Her research interests span materials engineering, biomedical engineering, materials chemistry, and nanotechnology, with a commitment to translating laboratory findings into clinical applications. With numerous publications in high-impact journals, she is recognized for her contributions to advancing biomedical science. Dr. Peng is passionate about improving patient outcomes and enhancing tissue repair through novel biomaterials-based strategies.

Profile

Google Scholar

Education

Dr. Peng Xiaoting holds an advanced academic background in materials engineering and biomedical sciences. She completed her undergraduate and graduate education in China, where she earned her Bachelor’s and Master’s degrees in Materials Science. Building on her foundational studies, she pursued a Ph.D. in Biomedical Engineering, focusing on the synthesis and application of biomaterials for medical use, particularly in cancer treatment and tissue regeneration. Throughout her academic career, Dr. Peng has collaborated with leading researchers in the fields of materials chemistry and nanotechnology, enhancing her interdisciplinary knowledge and expertise. Her education has provided her with a deep understanding of material properties at the molecular level, which she applies to the development of innovative biomedical solutions. She continues to build on this knowledge in her current postdoctoral research role, where she is involved in cutting-edge projects aimed at solving complex medical challenges using advanced biomaterials.

Experience

Dr. Peng Xiaoting has extensive experience in both academic research and practical applications of biomaterials in the biomedical field. As a postdoctoral researcher at the University of Health and Rehabilitation Sciences, she focuses on developing advanced biomaterials with applications in cancer treatment, tissue repair, and regeneration. She is involved in several ongoing projects, including those funded by the Qingdao Natural Science Foundation, demonstrating her ability to secure competitive research grants. Dr. Peng has published extensively in renowned scientific journals, contributing significantly to the understanding of self-assembly peptide-based materials and their potential for medical applications. Her research experience spans materials engineering, biomedical engineering, materials chemistry, and nanotechnology. Prior to her postdoctoral work, Dr. Peng gained experience in both laboratory-based research and theoretical study, allowing her to tackle real-world challenges in the field of biomedicine. She remains committed to advancing the translation of scientific discoveries into clinical therapies.

Research Focus

Dr. Peng Xiaoting’s research focuses on the development and application of advanced biomaterials for the diagnosis and treatment of complex diseases such as cancer, tissue injuries, and defects. She specializes in designing and synthesizing biomaterials that possess unique chemical, physical, and biological properties. Her work aims to bridge the gap between laboratory research and clinical applications by developing materials that can be utilized for tissue regeneration, drug delivery systems, and cancer therapy. Dr. Peng is particularly interested in self-assembly peptide-based materials, exploring their potential in stimulating tissue repair and enhancing therapeutic efficacy. Her expertise spans several interdisciplinary fields, including materials engineering, biomedical engineering, nanotechnology, and materials chemistry. Through her research, Dr. Peng seeks to push the boundaries of biomedical science and improve patient outcomes, particularly by advancing personalized and effective treatment strategies using novel biomaterials. Her ultimate goal is to contribute to the clinical translation of innovative biomaterials-based strategies.

Publication Top Notes

  1. Rapid Hemostasis Resulting from the Synergism of Self-Assembling Short Peptide and O-Carboxymethyl Chitosan 🩸🧬
  2. Modulation of antimicrobial peptide conformation and aggregation by terminal lipidation and surfactants 💊🧫
  3. Evaluation of a photocrosslinkable hydroxyethyl chitosan hydrogel as a potential drug release system for glaucoma surgery 👁️💉
  4. Catechol-stimulated crosslinking of catechol-conjugated hydroxyethyl chitosan as a tissue adhesive 🧪🩹
  5. Effects of conventional surfactants on the activity of designed antimicrobial peptide 🧴🦠
  6. Amyloid-like aggregates of short self-assembly peptide selectively induce melanoma cell apoptosis 🧬💀
  7. Chitosan as a tissue adhesive 💡🦠
  8. Catechol-conjugated hydroxyethyl chitosan as a tissue adhesive 🔬🩻

Fabian Kiessling | Biomedical Engineering Award |Outstanding Scientist Award

Prof Fabian Kiessling | Biomedical Engineering Award |Outstanding Scientist Award

Prof Fabian Kiessling , Institute for Experimental Molecular Imaging, RWTH Aachen University, Germany

👨‍🏫 Prof. Fabian Kiessling is a renowned expert in molecular imaging and diagnostic radiology, serving as a Full Professor at RWTH Aachen University and the Managing Director of the Helmholtz Institute for Biomedical Engineering. He holds an MD from Ruprecht-Karls University, Heidelberg, and has pioneered various research initiatives. His significant contributions include co-founding SonoMAC GmbH and invivoContrast GmbH. Prof. Kiessling’s work has been widely recognized, earning him prestigious awards such as the Clarivate Highly Cited Researcher and the Aachen Animal Welfare Award. His dedication to advancing medical imaging has made him a leader in his field. 🌟📚

Publication Profile

Scopus

Education

Prof. Fabian Kiessling has an illustrious career in diagnostic radiology and molecular imaging. He completed his medical studies at Ruprecht-Karls University, Heidelberg, from 1993-2000, earning his MD in 2001. He obtained board certification in diagnostic radiology in 2007 and achieved habilitation in 2006. His professional milestones include roles such as Managing Director at the Helmholtz-Institute for Biomedical Engineering (2023) and Full Professor at RWTH Aachen University (2008). He co-founded SonoMAC GmbH (2021) and invivoContrast GmbH (2008), significantly advancing biomedical research and digital medicine. 🌟🧬🏥

Research Focus

Prof. Fabian Kiessling’s research focuses on molecular imaging and biomedical engineering. His pioneering work in diagnostic radiology aims to enhance noninvasive imaging techniques for better disease detection and treatment. He explores innovative approaches in tumor models, vascular grafts, and ultrasound localization microscopy, significantly impacting cancer research and nanomedicine. Kiessling’s contributions are pivotal in advancing medical imaging technologies, fostering interdisciplinary collaboration, and translating scientific discoveries into clinical applications. His research is instrumental in improving diagnostic accuracy and patient outcomes. 🧪🔬📈

Publication Top Notes

“Nanoscale engineering of gold nanostars for enhanced photoacoustic imaging” by Zhang, R., Thoröe-Boveleth, S., Chigrin, D.N., … Lammers, T., Pallares, R.M., Journal of Nanobiotechnology, 2024, 22(1), 115. 📄🌟 Cited by: 0.

“CT- and MRI-Aided Fluorescence Tomography Reconstructions for Biodistribution Analysis” by Schraven, S., Brück, R., Rosenhain, S., … Gremse, F., Kiessling, F., Investigative Radiology, 2024, 59(7), pp. 504–512. 📄🧬 Cited by: 0.

“Ultrasound-induced immune responses in tumors: A systematic review and meta-analysis” by Rix, A., Heinrichs, H., Porte, C., … Bleich, A., Kiessling, F., Journal of Controlled Release, 2024, 371, pp. 146–157. 📄📊 Cited by: 0.

“Riboflavin-targeted polymers improve tolerance of paclitaxel while maintaining therapeutic efficacy” by Darguzyte, M., Rama, E., Rix, A., … Jankowski, J., Kiessling, F., Nanomedicine: Nanotechnology, Biology, and Medicine, 2024, 58, 102751. 📄💊 Cited by: 0.

“mRNA Sonotransfection of Tumors with Polymeric Microbubbles: Co-Formulation versus Co-Administration” by Chen, J., Wang, B., Wang, Y., … Rix, A., Kiessling, F., Advanced Science, 2024, 11(15), 2306139. 📄🧫 Cited by: 0.

“A Biodegradable Tissue Adhesive for Post-Extraction Alveolar Bone Regeneration under Ongoing Anticoagulation—A Microstructural Volumetric Analysis in a Rodent Model” by Heitzer, M., Winnand, P., Ooms, M., … Hölzle, F., Modabber, A., International Journal of Molecular Sciences, 2024, 25(8), 4210. 📄🐭 Cited by: 0.

“Engineering Mesoscopic 3D Tumor Models with a Self-Organizing Vascularized Matrix” by De Lorenzi, F., Hansen, N., Theek, B., … Fischer, H., Kiessling, F., Advanced Materials, 2024, 36(5), 2303196. 📄🧠 Cited by: 3.